Carmignac Gestion Lantheus Holdings, Inc. Transaction History
Carmignac Gestion
- $6.18 Billion
- Q4 2024
A detailed history of Carmignac Gestion transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Carmignac Gestion holds 232,700 shares of LNTH stock, worth $18.6 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
232,700
Previous 138,100
68.5%
Holding current value
$18.6 Million
Previous $15.2 Million
37.35%
% of portfolio
0.34%
Previous 0.26%
Shares
3 transactions
Others Institutions Holding LNTH
# of Institutions
532Shares Held
73MCall Options Held
598KPut Options Held
371K-
Black Rock Inc. New York, NY8.6MShares$688 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.24MShares$580 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.2MShares$496 Million0.29% of portfolio
-
Farallon Capital Management LLC San Francisco, CA5.32MShares$426 Million2.53% of portfolio
-
State Street Corp Boston, MA2.64MShares$211 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $5.5B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...